Cumulative high BP is better for predicting cardiovascular and death risk in type 2 diabetes patients: JACC
Australia: Cumulative systolic blood pressure (SBP) may better predict major cardiovascular events in type 2 diabetes patients compared with traditional BP measures, a recent study in the Journal of the American College of Cardiology (JACC) has claimed. Cumulative SBP is a measure that incorporates both the duration and magnitude of high blood pressure.
An increase in BP above optimal levels is the most usual chronic risk factor for cardiovascular disease worldwide, and CVD remains the forefront cause of disability and death. There seemed a continuous, log-linear relationship between levels of BP and CVD and mortality risk that extends to as low as 90 mm Hg. Previous studies have focused on single BP measurements from a particular cycle or age. These standard BP measures do not consider the magnitude and duration of elevated BP exposure over time. However, in recent years, there has been an increasing interest in actions that indicate aspects of BP exposure over time than at one point.
Against the above background, Nelson Wang, Royal Prince Alfred Hospital, Sydney, Australia, and colleagues aimed to investigate the association between cumulative SBP load and risk of cardiovascular events risk in type 2 diabetes patients.
For this purpose, the researchers conducted a post hoc analysis of type 2 diabetes patients followed by the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation - Observational Study (ADVANCE-ON).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.